Sickle cell disease: Difference between revisions

When treating avascular necrosis of the bone in people with sickle cell disease, the aim of treatment is to reduce or stop the pain and maintain [[joint]] mobility.<ref name=Marticarvajal2019>{{Cite journal|last1=Martí-Carvajal|first1=Arturo J.|last2=Solà|first2=Ivan|last3=Agreda-Pérez|first3=Luis H.|date=2019|title=Treatment for avascular necrosis of bone in people with sickle cell disease|url=|journal=The Cochrane Database of Systematic Reviews|volume=12|pages=CD004344|doi=10.1002/14651858.CD004344.pub7|issn=1469-493X|pmc=6894369|pmid=31803937}}</ref> Current treatment options include restresting the joint, [[Physiotherapy|physical therapy]], [[Pain Medicine|pain-relief medicine]], [[Joint replacement|joint-replacement surgery]], or [[bone grafting]].<ref name=Marticarvajal2019 /> High quality, randomized, controlled trials are needed to assess the most effective treatment option and determine if a combination of physical therapy and surgery is more effective than physical therapy alone.<ref name=Marticarvajal2019 />